nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—CYP2C19—Progesterone—uterine cancer	0.0666	0.583	CbGbCtD
Glucosamine—CYP2E1—Etoposide—uterine cancer	0.0476	0.417	CbGbCtD
Glucosamine—IFNG—exocrine gland—uterine cancer	0.0306	0.0922	CbGeAlD
Glucosamine—NFKB2—myometrium—uterine cancer	0.0251	0.0753	CbGeAlD
Glucosamine—MMP9—artery—uterine cancer	0.0226	0.0679	CbGeAlD
Glucosamine—NFKB2—uterine cervix—uterine cancer	0.0195	0.0586	CbGeAlD
Glucosamine—NFKB2—decidua—uterine cancer	0.0186	0.0559	CbGeAlD
Glucosamine—Cytarabine—POLD1—uterine cancer	0.0184	1	CrCbGaD
Glucosamine—NFKB2—mammalian vulva—uterine cancer	0.0171	0.0513	CbGeAlD
Glucosamine—NFKB2—female reproductive system—uterine cancer	0.0146	0.0439	CbGeAlD
Glucosamine—TNF—vagina—uterine cancer	0.0134	0.0403	CbGeAlD
Glucosamine—IFNG—epithelium—uterine cancer	0.0133	0.0401	CbGeAlD
Glucosamine—NFKB2—female gonad—uterine cancer	0.0133	0.04	CbGeAlD
Glucosamine—IFNG—renal system—uterine cancer	0.0124	0.0372	CbGeAlD
Glucosamine—IFNG—uterus—uterine cancer	0.011	0.0331	CbGeAlD
Glucosamine—IFNG—female reproductive system—uterine cancer	0.0099	0.0298	CbGeAlD
Glucosamine—IFNG—vagina—uterine cancer	0.00895	0.0269	CbGeAlD
Glucosamine—TNF—lymph node—uterine cancer	0.00867	0.0261	CbGeAlD
Glucosamine—MMP9—epithelium—uterine cancer	0.00856	0.0257	CbGeAlD
Glucosamine—NFKB2—lymph node—uterine cancer	0.00854	0.0257	CbGeAlD
Glucosamine—MMP9—uterine cervix—uterine cancer	0.00849	0.0255	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—uterine cancer	0.00825	0.0248	CbGeAlD
Glucosamine—MMP9—decidua—uterine cancer	0.00808	0.0243	CbGeAlD
Glucosamine—MMP9—renal system—uterine cancer	0.00794	0.0239	CbGeAlD
Glucosamine—MMP9—endometrium—uterine cancer	0.00767	0.0231	CbGeAlD
Glucosamine—MMP9—uterus—uterine cancer	0.00707	0.0213	CbGeAlD
Glucosamine—MMP9—female reproductive system—uterine cancer	0.00636	0.0191	CbGeAlD
Glucosamine—IFNG—lymph node—uterine cancer	0.00579	0.0174	CbGeAlD
Glucosamine—MMP9—female gonad—uterine cancer	0.00578	0.0174	CbGeAlD
Glucosamine—MMP9—lymph node—uterine cancer	0.00372	0.0112	CbGeAlD
Glucosamine—CYP2E1—renal system—uterine cancer	0.00262	0.00787	CbGeAlD
Glucosamine—CYP2C19—vagina—uterine cancer	0.00258	0.00775	CbGeAlD
Glucosamine—CYP2E1—female reproductive system—uterine cancer	0.00209	0.0063	CbGeAlD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.000535	0.001	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—AKT1—uterine cancer	0.000531	0.000992	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.00053	0.000991	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000529	0.000989	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—uterine cancer	0.000525	0.000981	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDKN2A—uterine cancer	0.000523	0.000978	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—uterine cancer	0.000502	0.000938	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—CDKN1B—uterine cancer	0.0005	0.000935	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000499	0.000934	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—AKT1—uterine cancer	0.000499	0.000933	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—AKT1—uterine cancer	0.000499	0.000933	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CXCL8—uterine cancer	0.000498	0.000931	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—PIK3CA—uterine cancer	0.000491	0.000919	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—AKT1—uterine cancer	0.000487	0.00091	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000486	0.000909	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000483	0.000904	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—uterine cancer	0.000478	0.000894	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000474	0.000886	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—EP300—uterine cancer	0.000471	0.00088	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—uterine cancer	0.000462	0.000863	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PTEN—uterine cancer	0.00046	0.000861	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HNF1B—uterine cancer	0.000458	0.000856	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCL2—uterine cancer	0.000457	0.000855	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—uterine cancer	0.000456	0.000852	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000455	0.000851	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—FGFR2—uterine cancer	0.000453	0.000848	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000451	0.000843	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000449	0.000839	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—uterine cancer	0.000438	0.000818	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.000437	0.000817	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000436	0.000815	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IRF1—uterine cancer	0.000432	0.000808	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—AKT1—uterine cancer	0.000428	0.0008	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000425	0.000794	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000424	0.000792	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—uterine cancer	0.000416	0.000777	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—NRAS—uterine cancer	0.000411	0.000768	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—uterine cancer	0.000406	0.000759	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—VEGFA—uterine cancer	0.000405	0.000756	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—AKT1—uterine cancer	0.000401	0.000751	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—uterine cancer	0.000397	0.000743	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—uterine cancer	0.000396	0.000741	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CDH1—uterine cancer	0.000387	0.000724	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—FBXW7—uterine cancer	0.000387	0.000724	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.000386	0.000722	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—AKT1—uterine cancer	0.000385	0.000719	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MET—uterine cancer	0.00038	0.00071	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000373	0.000697	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—uterine cancer	0.000372	0.000696	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDH1—uterine cancer	0.000363	0.000679	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—uterine cancer	0.000362	0.000677	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—uterine cancer	0.000361	0.000676	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—uterine cancer	0.000355	0.000664	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NRAS—uterine cancer	0.000354	0.000661	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—KRAS—uterine cancer	0.000353	0.000661	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000353	0.00066	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—uterine cancer	0.000353	0.00066	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CDKN1B—uterine cancer	0.000353	0.00066	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	0.000351	0.000656	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IRF1—uterine cancer	0.00035	0.000654	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	0.000346	0.000647	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—AKT1—uterine cancer	0.000345	0.000645	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—uterine cancer	0.000338	0.000631	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—AKT1—uterine cancer	0.000335	0.000627	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000335	0.000626	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.000333	0.000622	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SMAD3—uterine cancer	0.000331	0.000618	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.00033	0.000617	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKR1B10—uterine cancer	0.000328	0.000614	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	0.000327	0.000611	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PIK3CA—uterine cancer	0.000325	0.000607	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—uterine cancer	0.000317	0.000593	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SOCS3—uterine cancer	0.000317	0.000592	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FBXW7—uterine cancer	0.000314	0.000586	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.000313	0.000585	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000312	0.000583	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—CTNNB1—uterine cancer	0.000309	0.000577	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—uterine cancer	0.000306	0.000572	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.000305	0.000571	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—KRAS—uterine cancer	0.000305	0.000569	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—uterine cancer	0.000301	0.000563	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—uterine cancer	0.0003	0.000562	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—uterine cancer	0.000291	0.000544	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000289	0.00054	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—uterine cancer	0.000285	0.000532	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—uterine cancer	0.000283	0.000528	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—uterine cancer	0.000277	0.000519	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RNF43—uterine cancer	0.000272	0.000508	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MET—uterine cancer	0.000271	0.000506	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.000269	0.000504	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CTNNB1—uterine cancer	0.000268	0.000501	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000267	0.000499	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—uterine cancer	0.000265	0.000496	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—FGFR2—uterine cancer	0.000264	0.000494	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1B—uterine cancer	0.000264	0.000493	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000259	0.000485	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—uterine cancer	0.000259	0.000484	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	0.000258	0.000483	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	0.000258	0.000482	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SOCS3—uterine cancer	0.000257	0.00048	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	0.000255	0.000476	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CTNNB1—uterine cancer	0.000249	0.000466	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—INHBA—uterine cancer	0.000249	0.000465	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000248	0.000463	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.000248	0.000463	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—uterine cancer	0.000246	0.00046	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—uterine cancer	0.000246	0.00046	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PTEN—uterine cancer	0.000243	0.000454	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00024	0.000449	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000235	0.000439	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EP300—uterine cancer	0.000232	0.000433	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—uterine cancer	0.000229	0.000428	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—uterine cancer	0.000229	0.000427	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000227	0.000424	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000225	0.000421	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000225	0.000421	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKR1C1—uterine cancer	0.000224	0.000419	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—uterine cancer	0.000222	0.000415	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000221	0.000413	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—uterine cancer	0.000219	0.000409	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—uterine cancer	0.000217	0.000405	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FGFR2—uterine cancer	0.000214	0.0004	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—uterine cancer	0.000214	0.000399	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—uterine cancer	0.000211	0.000395	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000211	0.000394	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	0.00021	0.000393	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SMAD3—uterine cancer	0.000202	0.000378	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.000201	0.000376	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.0002	0.000373	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—uterine cancer	0.000198	0.00037	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDH1—uterine cancer	0.000197	0.000367	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—uterine cancer	0.000188	0.000352	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—uterine cancer	0.000186	0.000349	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—uterine cancer	0.000182	0.00034	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NDUFB11—uterine cancer	0.00018	0.000336	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SRD5A2—uterine cancer	0.00018	0.000336	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—uterine cancer	0.000178	0.000333	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CTNNB1—uterine cancer	0.000173	0.000324	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKR1C3—uterine cancer	0.000172	0.000322	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PIK3CA—uterine cancer	0.000171	0.00032	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.00017	0.000317	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PGR—uterine cancer	0.000168	0.000314	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—uterine cancer	0.000167	0.000313	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—uterine cancer	0.000166	0.00031	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MET—uterine cancer	0.000166	0.00031	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000165	0.000309	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.000164	0.000307	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EP300—uterine cancer	0.000161	0.000301	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—YWHAE—uterine cancer	0.00016	0.0003	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDH1—uterine cancer	0.000159	0.000298	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—uterine cancer	0.000158	0.000296	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000156	0.000292	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—uterine cancer	0.000154	0.000289	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FBXW7—uterine cancer	0.000154	0.000287	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1B—uterine cancer	0.000154	0.000287	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—uterine cancer	0.000152	0.000285	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000151	0.000282	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—uterine cancer	0.000151	0.000282	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—uterine cancer	0.000151	0.000282	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTNNB1—uterine cancer	0.000145	0.000271	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTEN—uterine cancer	0.000141	0.000264	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—uterine cancer	0.000141	0.000264	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—uterine cancer	0.00014	0.000262	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NDUFB11—uterine cancer	0.000139	0.000259	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SRD5A2—uterine cancer	0.000139	0.000259	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EP300—uterine cancer	0.000135	0.000252	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000135	0.000252	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—uterine cancer	0.000134	0.000251	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STK11—uterine cancer	0.000134	0.000251	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—STAR—uterine cancer	0.00013	0.000243	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKR1B1—uterine cancer	0.00013	0.000243	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—uterine cancer	0.00013	0.000242	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000127	0.000238	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000127	0.000238	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—uterine cancer	0.000126	0.000236	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SOCS3—uterine cancer	0.000126	0.000235	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1B—uterine cancer	0.000124	0.000233	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—uterine cancer	0.000121	0.000227	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN2B—uterine cancer	0.00012	0.000225	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTNNB1—uterine cancer	0.000118	0.00022	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1R—uterine cancer	0.000117	0.000219	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTEN—uterine cancer	0.000115	0.000214	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—uterine cancer	0.00011	0.000206	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMAD3—uterine cancer	0.00011	0.000206	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EP300—uterine cancer	0.000109	0.000204	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—uterine cancer	0.000109	0.000203	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CTNNB1—uterine cancer	0.000106	0.000198	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FGFR2—uterine cancer	0.000105	0.000196	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—uterine cancer	0.000102	0.000191	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—POLD1—uterine cancer	0.000102	0.000191	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKR1B1—uterine cancer	0.0001	0.000188	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—STAR—uterine cancer	0.0001	0.000188	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PIK3CA—uterine cancer	9.98e-05	0.000187	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.92e-05	0.000185	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EP300—uterine cancer	9.86e-05	0.000184	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—uterine cancer	9.73e-05	0.000182	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKR1C1—uterine cancer	9.55e-05	0.000178	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—uterine cancer	9.34e-05	0.000175	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—uterine cancer	9.23e-05	0.000173	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—uterine cancer	9.22e-05	0.000172	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ESR1—uterine cancer	8.97e-05	0.000168	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—uterine cancer	8.8e-05	0.000164	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—RRM2—uterine cancer	8.51e-05	0.000159	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—DCN—uterine cancer	8.26e-05	0.000154	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—uterine cancer	8.15e-05	0.000152	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PIK3CA—uterine cancer	8.08e-05	0.000151	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—uterine cancer	7.94e-05	0.000148	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—uterine cancer	7.9e-05	0.000148	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—POLD1—uterine cancer	7.87e-05	0.000147	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP11A1—uterine cancer	7.78e-05	0.000145	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—uterine cancer	7.48e-05	0.00014	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKR1C1—uterine cancer	7.37e-05	0.000138	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKR1C3—uterine cancer	7.35e-05	0.000137	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—uterine cancer	6.75e-05	0.000126	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—uterine cancer	6.6e-05	0.000123	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—uterine cancer	6.58e-05	0.000123	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—RRM2—uterine cancer	6.57e-05	0.000123	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—DCN—uterine cancer	6.37e-05	0.000119	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—uterine cancer	6.24e-05	0.000117	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1B—uterine cancer	6.1e-05	0.000114	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP11A1—uterine cancer	6e-05	0.000112	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—uterine cancer	5.96e-05	0.000111	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CTNNB1—uterine cancer	5.76e-05	0.000108	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP19A1—uterine cancer	5.73e-05	0.000107	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—STK11—uterine cancer	5.73e-05	0.000107	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKR1C3—uterine cancer	5.67e-05	0.000106	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTEN—uterine cancer	5.61e-05	0.000105	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EP300—uterine cancer	5.35e-05	0.0001	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—uterine cancer	5.07e-05	9.48e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—uterine cancer	5.01e-05	9.36e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP19A1—uterine cancer	4.42e-05	8.26e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—STK11—uterine cancer	4.42e-05	8.26e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—uterine cancer	4.31e-05	8.06e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTHFR—uterine cancer	4.3e-05	8.04e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.15e-05	7.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CA—uterine cancer	3.96e-05	7.41e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.95e-05	7.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—uterine cancer	3.83e-05	7.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—uterine cancer	3.66e-05	6.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTHFR—uterine cancer	3.32e-05	6.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—uterine cancer	3.24e-05	6.05e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.93e-05	5.47e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTEN—uterine cancer	2.39e-05	4.47e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—EP300—uterine cancer	2.28e-05	4.27e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTEN—uterine cancer	1.85e-05	3.45e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—EP300—uterine cancer	1.76e-05	3.29e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.69e-05	3.16e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—uterine cancer	1.38e-05	2.58e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.3e-05	2.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—uterine cancer	1.06e-05	1.99e-05	CbGpPWpGaD
